Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study
NCT06774690
Summary
The goal of this observational study is to learn what are the best conditions that will give a positive outcome to men and women that receive a intra arterial therapy (IAT) for primary liver cancer. Intra arterial therapies are radiologic procedures that block liver cancer blood supply. The researchers will collect the data of participants located in the Radiology department in "IRCCS Azienda Ospedaliera Universitaria" Hospital in Bologna and will study clinic and radiological traits to understand which is the best case scenario for a optimal treatment response.
Eligibility
Inclusion Criteria: * diagnosis of Hepatocellular carcinoma (HCC) or intrahepatic cholangiocarcinoma (iCCA) and clinical indication to receive or have already received one of the following treatments: * Trans-arterial embolization (TAE), * Transarterial chemoembolization (TACE), * Transarterial radioembolization (TARE) * Drug-eluting beads chemoembolization (DEB-TACE) * Age over 18 * To give informed consent Exclusion Criteria: * shunt of gastro intestinal arteries that cannot be embolized * metastasis spread outside of the liver * liver failure
Conditions5
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06774690